parkinson's disease retatrutide clinical trial Researchers evaluate a pipeline of trials targeting Time-to-event analysis mitigates the impact – retatrutide parkinson's clinical trial disease

As seen in Figure 3a and b, the GLP1R-expressing cells corresponded to insulin-producing cells

Data specific to this study including diagnosis codes and cohort characteristics in aggregated format are included in the manuscript as tables, figures, and supplementary files

(1) Given that osteoarthritis (OA) is the leading indication for arthroplasty and obesity is the most significant modifiable risk factor for OA development, it is unsurprising that a substantial proportion of arthroplasty patients are affected by obesity

Renal function should be monitored when significant gastrointestinal symptoms occur due to risk of dehydration and acute kidney injury

However, rare but severe side effects, such as pancreatitis or gallbladder issues, require immediate medical attention